ixazomib 4 MG Oral Capsule

RxCUI: 1723770
RxNorm name: ixazomib 4 MG Oral Capsule
Display name: ixazomib 4 MG Oral Capsule
Full name: ixazomib 4 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NINLARO	IXAZOMIB	Takeda Pharmaceuticals America, Inc.	038f2461-834b-4488-9ebd-863c83eef5a7	2025-08-18	Warnings, Adverse reactions	Exact identifier rxcui: 1723770

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
038f2461-834b-4488-9ebd-863c83eef5a7	ixazomib 4 MG Oral Capsule	PSN	16	These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015	20250818
038f2461-834b-4488-9ebd-863c83eef5a7	ixazomib 4 MG Oral Capsule	SCD	16	These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015	20250818
038f2461-834b-4488-9ebd-863c83eef5a7	ixazomib 4 MG (as ixazomib citrate 5.7 MG) Oral Capsule	SY	16	These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015	20250818